A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients

NCT07404202 · clinicaltrials.gov ↗

RECRUITING

Status

2100

Enrollment

INDUSTRY

Sponsor class

Conditions

Pan-tumor(NSCLC, GYN Cancers, BTC and UC)

Sponsor

AstraZeneca